Gemcitabine is ineffective in recurrent, preirradiated cervical cancer

A new low uncertainty measurement of the 111Ag half-life.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026

Particle Beam Re-irradiation in Oligo Recurrent Gynecological Malignancies.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Radiomics-based ultrasOund Model for differentiating Uterine Sarcomas from leiomyomas (ROMUS): a retrospective pilot Multicenter Italian Trials in Ovarian Cancer (MITO) study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial.

ESMO open·2026

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.

ESMO open·2025

Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model.

Gynecologic oncology·2026

The science and conduct of surgical trials in gynecologic oncology: A practical framework.

Gynecologic oncology·2026

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Gynecologic oncology·2026

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Gynecologic oncology·2026

Lycopus lucidus Extract Improves Experimental Polycystic Ovary Syndrome with Gut Microbiota and Metabolome Remodeling.

Journal of visualized experiments : JoVE·2026

A critical appraisal evaluating the efficacy of extracorporeal shock wave therapy in coccydynia.

International journal for advancing practice·2026

Global trends in the management of carotid artery stenosis: A bibliometric analysis from 2012 to 2022.

Brain circulation·2026

Unlocking the brain: Biodistribution insights into tween 80 nanoliposomes in healthy brains.

International journal of pharmaceutics: X·2026

Relapse-free survival and metastasis-free survival between patients with breast cancer receiving adjuvant or neoadjuvant therapy: A retrospective study in Iran.

Caspian journal of internal medicine·2026

Outcomes of Laser Interstitial Thermal Therapy-Augmented Surgery in the Management of Subcortical Glioblastoma.

Neurosurgery practice·2026

Related Experiment Videos

Gemcitabine is ineffective in recurrent, preirradiated cervical cancer

Related Concept Videos

A new low uncertainty measurement of the 111Ag half-life.

Particle Beam Re-irradiation in Oligo Recurrent Gynecological Malignancies.

Radiomics-based ultrasOund Model for differentiating Uterine Sarcomas from leiomyomas (ROMUS): a retrospective pilot Multicenter Italian Trials in Ovarian Cancer (MITO) study.

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial.

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.

Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model.

The science and conduct of surgical trials in gynecologic oncology: A practical framework.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Lycopus lucidus Extract Improves Experimental Polycystic Ovary Syndrome with Gut Microbiota and Metabolome Remodeling.

A critical appraisal evaluating the efficacy of extracorporeal shock wave therapy in coccydynia.

Global trends in the management of carotid artery stenosis: A bibliometric analysis from 2012 to 2022.

Unlocking the brain: Biodistribution insights into tween 80 nanoliposomes in healthy brains.

Relapse-free survival and metastasis-free survival between patients with breast cancer receiving adjuvant or neoadjuvant therapy: A retrospective study in Iran.

Outcomes of Laser Interstitial Thermal Therapy-Augmented Surgery in the Management of Subcortical Glioblastoma.

Related Experiment Videos

Gemcitabine is ineffective in recurrent, preirradiated cervical cancer

Related Concept Videos

Related Articles